<?xml version="1.0" encoding="UTF-8"?>
<p>Early clinical data on the evolution of COVID-19 patients pointed out to a deleterious influence of ibuprofen and ketoprofen even taken as short as 2–4 days during the onset of the infection (
 <xref rid="B28" ref-type="bibr">ANSES, 2020</xref>), and prompted French authorities to discourage public to use NSAIDs other than paracetamol. Later data did not clearly substantiate the link between NSAIDs and worsening of the symptoms, so EMA released a communication clarifying this point and calling for rational use of NSAIDs ‘at the lowest effective dose for the shortest possible period’ (
 <xref rid="B170" ref-type="bibr">EMA, 2020</xref>).
</p>
